Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Regenerative Drugs Revenue 1.4 Market Analysis by Type 1.4.1 Global Regenerative Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Synthetic Material 1.4.3 Biologically Derived Material 1.4.4 Genetically Engineered Material 1.4.5 Others 1.5 Market by Application 1.5.1 Global Regenerative Drugs Market Share by Application: 2020 VS 2026 1.5.2 Cardiovascular 1.5.3 Dermatology 1.5.4 Musculoskeletal 1.5.5 Neurology 1.5.6 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Regenerative Drugs Market Perspective (2015-2026) 2.2 Regenerative Drugs Growth Trends by Regions 2.2.1 Regenerative Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Regenerative Drugs Historic Market Share by Regions (2015-2020) 2.2.3 Regenerative Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Regenerative Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key Regenerative Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Regenerative Drugs Players by Market Size 3.1.1 Global Top Regenerative Drugs Players by Revenue (2015-2020) 3.1.2 Global Regenerative Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global Regenerative Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Regenerative Drugs Market Concentration Ratio 3.2.1 Global Regenerative Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Regenerative Drugs Revenue in 2019 3.3 Regenerative Drugs Key Players Head office and Area Served 3.4 Key Players Regenerative Drugs Product Solution and Service 3.5 Date of Enter into Regenerative Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Regenerative Drugs Historic Market Size by Type (2015-2020) 4.2 Global Regenerative Drugs Forecasted Market Size by Type (2021-2026) 5 Regenerative Drugs Breakdown Data by Application (2015-2026) 5.1 Global Regenerative Drugs Market Size by Application (2015-2020) 5.2 Global Regenerative Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Regenerative Drugs Market Size (2015-2020) 6.2 Regenerative Drugs Key Players in North America (2019-2020) 6.3 North America Regenerative Drugs Market Size by Type (2015-2020) 6.4 North America Regenerative Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe Regenerative Drugs Market Size (2015-2020) 7.2 Regenerative Drugs Key Players in Europe (2019-2020) 7.3 Europe Regenerative Drugs Market Size by Type (2015-2020) 7.4 Europe Regenerative Drugs Market Size by Application (2015-2020) 8 China 8.1 China Regenerative Drugs Market Size (2015-2020) 8.2 Regenerative Drugs Key Players in China (2019-2020) 8.3 China Regenerative Drugs Market Size by Type (2015-2020) 8.4 China Regenerative Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan Regenerative Drugs Market Size (2015-2020) 9.2 Regenerative Drugs Key Players in Japan (2019-2020) 9.3 Japan Regenerative Drugs Market Size by Type (2015-2020) 9.4 Japan Regenerative Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Regenerative Drugs Market Size (2015-2020) 10.2 Regenerative Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Regenerative Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia Regenerative Drugs Market Size by Application (2015-2020) 11 India 11.1 India Regenerative Drugs Market Size (2015-2020) 11.2 Regenerative Drugs Key Players in India (2019-2020) 11.3 India Regenerative Drugs Market Size by Type (2015-2020) 11.4 India Regenerative Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Regenerative Drugs Market Size (2015-2020) 12.2 Regenerative Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America Regenerative Drugs Market Size by Type (2015-2020) 12.4 Central & South America Regenerative Drugs Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Stryker 13.1.1 Stryker Company Details 13.1.2 Stryker Business Overview and Its Total Revenue 13.1.3 Stryker Regenerative Drugs Introduction 13.1.4 Stryker Revenue in Regenerative Drugs Business (2015-2020)) 13.1.5 Stryker Recent Development 13.2 Zimmer Biomet Holdings 13.2.1 Zimmer Biomet Holdings Company Details 13.2.2 Zimmer Biomet Holdings Business Overview and Its Total Revenue 13.2.3 Zimmer Biomet Holdings Regenerative Drugs Introduction 13.2.4 Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2015-2020) 13.2.5 Zimmer Biomet Holdings Recent Development 13.3 Medtronic 13.3.1 Medtronic Company Details 13.3.2 Medtronic Business Overview and Its Total Revenue 13.3.3 Medtronic Regenerative Drugs Introduction 13.3.4 Medtronic Revenue in Regenerative Drugs Business (2015-2020) 13.3.5 Medtronic Recent Development 13.4 Athersys 13.4.1 Athersys Company Details 13.4.2 Athersys Business Overview and Its Total Revenue 13.4.3 Athersys Regenerative Drugs Introduction 13.4.4 Athersys Revenue in Regenerative Drugs Business (2015-2020) 13.4.5 Athersys Recent Development 13.5 STEMCELL Technologies 13.5.1 STEMCELL Technologies Company Details 13.5.2 STEMCELL Technologies Business Overview and Its Total Revenue 13.5.3 STEMCELL Technologies Regenerative Drugs Introduction 13.5.4 STEMCELL Technologies Revenue in Regenerative Drugs Business (2015-2020) 13.5.5 STEMCELL Technologies Recent Development 13.6 Organogenesis 13.6.1 Organogenesis Company Details 13.6.2 Organogenesis Business Overview and Its Total Revenue 13.6.3 Organogenesis Regenerative Drugs Introduction 13.6.4 Organogenesis Revenue in Regenerative Drugs Business (2015-2020) 13.6.5 Organogenesis Recent Development 13.7 Integra Lifesciences 13.7.1 Integra Lifesciences Company Details 13.7.2 Integra Lifesciences Business Overview and Its Total Revenue 13.7.3 Integra Lifesciences Regenerative Drugs Introduction 13.7.4 Integra Lifesciences Revenue in Regenerative Drugs Business (2015-2020) 13.7.5 Integra Lifesciences Recent Development 13.8 Acelity 13.8.1 Acelity Company Details 13.8.2 Acelity Business Overview and Its Total Revenue 13.8.3 Acelity Regenerative Drugs Introduction 13.8.4 Acelity Revenue in Regenerative Drugs Business (2015-2020) 13.8.5 Acelity Recent Development 13.9 Isto Biologics 13.9.1 Isto Biologics Company Details 13.9.2 Isto Biologics Business Overview and Its Total Revenue 13.9.3 Isto Biologics Regenerative Drugs Introduction 13.9.4 Isto Biologics Revenue in Regenerative Drugs Business (2015-2020) 13.9.5 Isto Biologics Recent Development 13.10 CryoLife 13.10.1 CryoLife Company Details 13.10.2 CryoLife Business Overview and Its Total Revenue 13.10.3 CryoLife Regenerative Drugs Introduction 13.10.4 CryoLife Revenue in Regenerative Drugs Business (2015-2020) 13.10.5 CryoLife Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Regenerative Drugs Key Market Segments Table 2. Key Players Covered: Ranking by Regenerative Drugs Revenue Table 3. Ranking of Global Top Regenerative Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Regenerative Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Synthetic Material Table 6. Key Players of Biologically Derived Material Table 7. Key Players of Genetically Engineered Material Table 8. Key Players of Others Table 9. Global Regenerative Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Regenerative Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Regenerative Drugs Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Regenerative Drugs Market Share by Regions (2015-2020) Table 13. Global Regenerative Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Regenerative Drugs Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Regenerative Drugs Market Growth Strategy Table 19. Main Points Interviewed from Key Regenerative Drugs Players Table 20. Global Regenerative Drugs Revenue by Players (2015-2020) (Million US$) Table 21. Global Regenerative Drugs Market Share by Players (2015-2020) Table 22. Global Top Regenerative Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Drugs as of 2019) Table 23. Global Regenerative Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Regenerative Drugs Product Solution and Service Table 26. Date of Enter into Regenerative Drugs Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 29. Global Regenerative Drugs Market Size Share by Type (2015-2020) Table 30. Global Regenerative Drugs Revenue Market Share by Type (2021-2026) Table 31. Global Regenerative Drugs Market Size Share by Application (2015-2020) Table 32. Global Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 33. Global Regenerative Drugs Market Size Share by Application (2021-2026) Table 34. North America Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 35. North America Key Players Regenerative Drugs Market Share (2019-2020) Table 36. North America Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 37. North America Regenerative Drugs Market Share by Type (2015-2020) Table 38. North America Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 39. North America Regenerative Drugs Market Share by Application (2015-2020) Table 40. Europe Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Regenerative Drugs Market Share (2019-2020) Table 42. Europe Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 43. Europe Regenerative Drugs Market Share by Type (2015-2020) Table 44. Europe Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 45. Europe Regenerative Drugs Market Share by Application (2015-2020) Table 46. China Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 47. China Key Players Regenerative Drugs Market Share (2019-2020) Table 48. China Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 49. China Regenerative Drugs Market Share by Type (2015-2020) Table 50. China Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 51. China Regenerative Drugs Market Share by Application (2015-2020) Table 52. Japan Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Regenerative Drugs Market Share (2019-2020) Table 54. Japan Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 55. Japan Regenerative Drugs Market Share by Type (2015-2020) Table 56. Japan Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 57. Japan Regenerative Drugs Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Regenerative Drugs Market Share (2019-2020) Table 60. Southeast Asia Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Regenerative Drugs Market Share by Type (2015-2020) Table 62. Southeast Asia Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Regenerative Drugs Market Share by Application (2015-2020) Table 64. India Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 65. India Key Players Regenerative Drugs Market Share (2019-2020) Table 66. India Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 67. India Regenerative Drugs Market Share by Type (2015-2020) Table 68. India Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 69. India Regenerative Drugs Market Share by Application (2015-2020) Table 70. Central & South America Key Players Regenerative Drugs Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Regenerative Drugs Market Share (2019-2020) Table 72. Central & South America Regenerative Drugs Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Regenerative Drugs Market Share by Type (2015-2020) Table 74. Central & South America Regenerative Drugs Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Regenerative Drugs Market Share by Application (2015-2020) Table 76. Stryker Company Details Table 77. Stryker Business Overview Table 78. Stryker Product Table 79. Stryker Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 80. Stryker Recent Development Table 81. Zimmer Biomet Holdings Company Details Table 82. Zimmer Biomet Holdings Business Overview Table 83. Zimmer Biomet Holdings Product Table 84. Zimmer Biomet Holdings Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 85. Zimmer Biomet Holdings Recent Development Table 86. Medtronic Company Details Table 87. Medtronic Business Overview Table 88. Medtronic Product Table 89. Medtronic Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 90. Medtronic Recent Development Table 91. Athersys Company Details Table 92. Athersys Business Overview Table 93. Athersys Product Table 94. Athersys Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 95. Athersys Recent Development Table 96. STEMCELL Technologies Company Details Table 97. STEMCELL Technologies Business Overview Table 98. STEMCELL Technologies Product Table 99. STEMCELL Technologies Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 100. STEMCELL Technologies Recent Development Table 101. Organogenesis Company Details Table 102. Organogenesis Business Overview Table 103. Organogenesis Product Table 104. Organogenesis Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 105. Organogenesis Recent Development Table 106. Integra Lifesciences Company Details Table 107. Integra Lifesciences Business Overview Table 108. Integra Lifesciences Product Table 109. Integra Lifesciences Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 110. Integra Lifesciences Recent Development Table 111. Acelity Business Overview Table 112. Acelity Product Table 113. Acelity Company Details Table 114. Acelity Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 115. Acelity Recent Development Table 116. Isto Biologics Company Details Table 117. Isto Biologics Business Overview Table 118. Isto Biologics Product Table 119. Isto Biologics Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 120. Isto Biologics Recent Development Table 121. CryoLife Company Details Table 122. CryoLife Business Overview Table 123. CryoLife Product Table 124. CryoLife Revenue in Regenerative Drugs Business (2015-2020) (Million US$) Table 125. CryoLife Recent Development Table 126. Research Programs/Design for This Report Table 127. Key Data Information from Secondary Sources Table 128. Key Data Information from Primary Sources List of Figures Figure 1. Global Regenerative Drugs Market Share by Type: 2020 VS 2026 Figure 2. Synthetic Material Features Figure 3. Biologically Derived Material Features Figure 4. Genetically Engineered Material Features Figure 5. Others Features Figure 6. Global Regenerative Drugs Market Share by Application: 2020 VS 2026 Figure 7. Cardiovascular Case Studies Figure 8. Dermatology Case Studies Figure 9. Musculoskeletal Case Studies Figure 10. Neurology Case Studies Figure 11. Others Case Studies Figure 12. Regenerative Drugs Report Years Considered Figure 13. Global Regenerative Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Regenerative Drugs Market Share by Regions: 2020 VS 2026 Figure 15. Global Regenerative Drugs Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Regenerative Drugs Market Share by Players in 2019 Figure 18. Global Top Regenerative Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Drugs as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Regenerative Drugs Revenue in 2019 Figure 20. North America Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. China Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Japan Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Southeast Asia Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. India Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Central & South America Regenerative Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Stryker Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Stryker Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 29. Zimmer Biomet Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Zimmer Biomet Holdings Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 31. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Medtronic Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 33. Athersys Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Athersys Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 35. STEMCELL Technologies Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. STEMCELL Technologies Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 37. Organogenesis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Organogenesis Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 39. Integra Lifesciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Integra Lifesciences Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 41. Acelity Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Acelity Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 43. Isto Biologics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Isto Biologics Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 45. CryoLife Total Revenue (US$ Million): 2019 Compared with 2018 Figure 46. CryoLife Revenue Growth Rate in Regenerative Drugs Business (2015-2020) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation Figure 49. Key Executives Interviewed

Stryker Zimmer Biomet Holdings Medtronic Athersys STEMCELL Technologies Organogenesis Integra Lifesciences Acelity Isto Biologics CryoLife